Strattera Maker to Face Consumer Claim for 9-Year-Old's Suicide

OMAHA, Neb. - A federal judge has allowed the parents and siblings of a 9-year-old who committed suicide after taking the attention deficit disorder drug Strattera to amend their complaint to include a deceptive trade practices claim. Doyle v. Eli Lilly & Co., No. 06-412 (D. Neb.).

Magistrate Judge Thomas D. Thalken of the U.S. District Court of Nebraska ruled Jan. 24 that the issue of whether the family of Sean Doyle can prevail on their claim against Eli Lilly & Co. for violation of the state Consumer Protection Act should be decided on the merits, not in a decision …